Status:
COMPLETED
Neuropsychological Indicators of SCD Progression
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Biomarkers
Cognitive Assessment
Eligibility:
All Genders
18+ years
Brief Summary
Some patients with subjective cognitive decline (SCD) progress to neurocognitive disorders (NCD), whereas others remain stable; however, the neuropsychological determinants of this progression have no...
Eligibility Criteria
Inclusion
- patients who had been referred to the memory center at Amiens University Medical Center (Amiens, France).
- patients who had undergone three neuropsychological assessments at least 6 months apart, from 2005
- patients who met the criteria for SCD.
Exclusion
- patients who didn't meet the criteria for SCD
Key Trial Info
Start Date :
May 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04880252
Start Date
May 1 2019
End Date
May 1 2020
Last Update
May 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80480